Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Viruses
|
January 10, 2014
Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts
Sabine Reyda, Nicole Büscher, Stefan Tenzer, et al.
Biological Chemistry
|
November 20, 2002
Trypsin mutants for structure-based drug design: expression, refolding and crystallisation
Daniel Rauh, Sabine Reyda, Gerhard Klebe, et al.
Medical Microbiology and Immunology
|
March 6, 2008
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine
Véronique Mersseman, Verena Böhm, Rafaela Holtappels, et al.
The Journal of General Virology
|
January 17, 2008
Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies
Véronique Mersseman, Katrin Besold, Matthias J Reddehase, et al.
Journal of Virology
|
June 13, 2014
The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles
Sabine Reyda, Stefan Tenzer, Pedro Navarro, et al.
Journal of Molecular Biology
|
January 16, 2003
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity
Sabine Reyda, Christian Sohn, Gerhard Klebe, et al.
Journal of Virology
|
March 2, 2013
Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection
Julia Hesse, Sabine Reyda, Stefan Tenzer, et al.
Vaccine
|
July 27, 2010
Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant
Sabine Becke, Steffi Aue, Doris Thomas, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 24, 2025
Protease-activated receptor 4 deficiency increases mortality, intracranial bleeding, and blood-brain barrier impairment following traumatic brain injury in mice
Leonie S Link, Christina Gölz, Regina Hummel, et al.
The Journal of General Virology
|
July 2, 2010
Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells
Sabine Becke, Véronique Fabre-Mersseman, Steffi Aue, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Viruses
|
January 10, 2014
Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts
Sabine Reyda, Nicole Büscher, Stefan Tenzer, et al.
Biological Chemistry
|
November 20, 2002
Trypsin mutants for structure-based drug design: expression, refolding and crystallisation
Daniel Rauh, Sabine Reyda, Gerhard Klebe, et al.
Medical Microbiology and Immunology
|
March 6, 2008
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine
Véronique Mersseman, Verena Böhm, Rafaela Holtappels, et al.
The Journal of General Virology
|
January 17, 2008
Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies
Véronique Mersseman, Katrin Besold, Matthias J Reddehase, et al.
Journal of Virology
|
June 13, 2014
The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles
Sabine Reyda, Stefan Tenzer, Pedro Navarro, et al.
Journal of Molecular Biology
|
January 16, 2003
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity
Sabine Reyda, Christian Sohn, Gerhard Klebe, et al.
Journal of Virology
|
March 2, 2013
Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection
Julia Hesse, Sabine Reyda, Stefan Tenzer, et al.
Vaccine
|
July 27, 2010
Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant
Sabine Becke, Steffi Aue, Doris Thomas, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 24, 2025
Protease-activated receptor 4 deficiency increases mortality, intracranial bleeding, and blood-brain barrier impairment following traumatic brain injury in mice
Leonie S Link, Christina Gölz, Regina Hummel, et al.
The Journal of General Virology
|
July 2, 2010
Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells
Sabine Becke, Véronique Fabre-Mersseman, Steffi Aue, et al.
Page
of 2